[HTML][HTML] Regional survey of tuberculosis risk assessment in rheumatology outpatients commencing anti-TNF-α treatment in relation to British Thoracic Society …
H John, C Buckley, L Koh, K Obrenovic, N Erb… - Clinical …, 2009 - ncbi.nlm.nih.gov
The aim of this study was to analyse tuberculosis (TB) risk assessment for rheumatology
patients commencing anti-tumour necrosis factor-α (anti-TNF-α) therapy using the British …
patients commencing anti-tumour necrosis factor-α (anti-TNF-α) therapy using the British …
British Thoracic Society (BTS) recommendations for assessing risk and managing tuberculosis in patients due to start anti-TNF-α treatments
J Ledingham, C Wilkinson, C Deighton - Rheumatology, 2005 - academic.oup.com
Anti-TNF drugs have revolutionized rheumatology practice. However, these new drugs have
also created new problems that UK rheumatologists have rarely had to consider in their …
also created new problems that UK rheumatologists have rarely had to consider in their …
Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of …
A Singanayagam, K Manalan, S Sridhar, PL Molyneaux… - Thorax, 2013 - thorax.bmj.com
Background Patients undergoing tumour necrosis factor (TNF)-α antagonist therapy are at
increased risk of latent tuberculosis infection (LTBI) reactivation. The aim of this study was to …
increased risk of latent tuberculosis infection (LTBI) reactivation. The aim of this study was to …
Tuberculosis screening in prescribers of anti-tumor necrosis factor therapy in the European Union
MY Smith, B Attig, L McNamee… - The International journal …, 2012 - ingentaconnect.com
SETTING: Physician offices and hospital-based settings in 24 European Union countries.
OBJECTIVES: To assess the awareness of tuberculosis (TB) risk, performance of TB …
OBJECTIVES: To assess the awareness of tuberculosis (TB) risk, performance of TB …
Tuberculosis screening before and during treatment with tumor necrosis factor antagonists: something old, something new
The increased risk of tuberculosis (TB) with tumor necrosis factor (TNF-α) antagonist
treatment is well recognized1. The risk seems to parallel the background risk of TB. In Spain …
treatment is well recognized1. The risk seems to parallel the background risk of TB. In Spain …
Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis
L Sichletidis, L Settas, D Spyratos… - … of Tuberculosis and …, 2006 - ingentaconnect.com
SETTING: A major concern surrounding the use of tumor necrosis factor-alpha (TNF-α)
inhibitors is their potential to increase the risk of opportunistic infections, particularly …
inhibitors is their potential to increase the risk of opportunistic infections, particularly …
[PDF][PDF] BTS recommendations for assessing risk, and for managing M. tuberculosis infection and disease, in patients due to start anti-TNF treatment
P Ormerod, HJ Milburn, S Gillespie, J Ledingham… - Thorax, 2005 - thorax.bmj.com
In view of the increased risk of TB reactivation with anti-TNF alpha treatment, various
professional groups have sought the advice of the Joint Tuberculosis Committee of the …
professional groups have sought the advice of the Joint Tuberculosis Committee of the …
Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis
T Cagatay, M Aydın, S Sunmez, P Cagatay… - Rheumatology …, 2010 - Springer
The objective of this study is to estimate the incidence of active tuberculosis in patients with
inflammatory diseases receiving tumor necrosis factor-alpha (TNF-α) antagonists and to …
inflammatory diseases receiving tumor necrosis factor-alpha (TNF-α) antagonists and to …
Risk of active tuberculosis in patients with inflammatory arthritis receiving TNF inhibitors: a look beyond the baseline tuberculosis screening protocol
A Soare, AM Gheorghiu, V Aramă, D Bumbăcea… - Clinical …, 2018 - Springer
Tuberculosis (TB) is a major concern in patients receiving TNF inhibitors (TNFi). This study
aimed to assess the incidence of active TB and the efficacy of TB prevention measures used …
aimed to assess the incidence of active TB and the efficacy of TB prevention measures used …
Tuberculosis among patients treated with TNF inhibitors for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis in Slovenia: a cohort study
Z Rotar, P Svetina, M Tomsic, A Hočevar… - BMJ open, 2020 - bmjopen.bmj.com
Objectives This study aimed to assess the risk of tuberculosis (TB) in patients with
rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) treated …
rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) treated …